Gubra A/S
CRO & biotech accelerating peptide drug discovery for metabolic and fibrotic diseases.
GUBRA | CO
Overview
Corporate Details
- ISIN(s):
- DK0062266474
- LEI:
- 254900T17RRFZONO6W53
- Country:
- Denmark
- Address:
- Hørsholm Kongevej 11 B, 2970 Hørsholm
- Website:
- https://www.gubra.dk/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Gubra A/S is a specialized preclinical Contract Research Organization (CRO) and biotechnology company focused on peptide-based drug discovery for metabolic and fibrotic diseases, such as obesity, diabetes, and MASH. Founded in 2008, the company operates through two primary business areas: CRO Services, providing advanced preclinical research to accelerate partners' drug development, and Discovery & Partnerships, which develops its own pipeline of next-generation peptide therapeutics. Gubra leverages its expertise in in vivo pharmacology and peptide chemistry to streamline and advance early-stage drug development for its clients and internal projects.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Gubra A/S filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Gubra A/S via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
